Li Shuling, Zhan Hongmou, Peng Shukun
Department of Otorhinolaryngology, the First Affiliated Hospital of Kunming Medical College, Yunnan, 650032, China.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008 Nov;22(21):987-91.
This study aimed to analyze the expression of epidermal growth factor receptor (EGFR), Ki67 and p16 in human middle ear cholesteatomas and to investigate the correlation between its expression and the ability of erosion of cholesteatoma.
The specimens from the acquired middle ear cholesteatoma tissue of 30 cases and 21 external ear canal skin samples from patients and 17 external ear canal skin samples from healthful men were taken intraoperatively. Their expression was examined by immunohistochemical SP method. Then we scanned it into a computer by an image scanner and quantified the gray of them using commercial software.
The percent of positive expression of EGFR, Ki67 and p16 in middle ear cholesteatoma were 70.0%, 60.0%, 46.7%. Their expression tended to the increased greatly compared with the skins of the control groups. There was not correlation between the expression of EGFR, Ki67 and p16 (P > 0.05). It showed statistically significant correlation between expression of EGFR and the ability of erosion of middle ear cholesteatoma (P < 0.01). There was correlation between the expression of Ki67 and the ability of erosion of middle ear cholesteatoma too (P < 0.01). But there was not correlation between the expression of p16 and the ability of erosion of middle ear cholesteatoma (P > 0.05). The expression of EGFR, Ki67, p16 in all epithelial layers of middle ear cholesteatoma were abundantly stained, especially in the basal and spinous layers. Only the basal layer were slightly stained in control groups.
The expression of EGFR, Ki67, p16 in middle ear cholesteatoma was significantly high-er compared with the skin of external auditory of cholesteatoma patients and healthful peoples. There was correlation between the expression of EGFR or Ki67 and the ability of erosion of middle ear cholesteatoma. It means that EGFR, Ki67 and p16 play a key role in the hyperproliferation middle ear cholesteatoma.
本研究旨在分析表皮生长因子受体(EGFR)、Ki67和p16在人中耳胆脂瘤中的表达情况,并探讨其表达与胆脂瘤侵蚀能力之间的相关性。
术中采集30例获得性中耳胆脂瘤组织标本、21例患者外耳道皮肤样本以及17例健康男性外耳道皮肤样本。采用免疫组织化学SP法检测其表达。然后用图像扫描仪将其扫描进计算机,并用商业软件对其灰度进行量化。
中耳胆脂瘤中EGFR、Ki67和p16的阳性表达率分别为70.0%、60.0%、46.7%。与对照组皮肤相比,它们的表达明显升高。EGFR、Ki67和p16的表达之间无相关性(P>0.05)。EGFR表达与中耳胆脂瘤侵蚀能力之间存在统计学显著相关性(P<0.01)。Ki67表达与中耳胆脂瘤侵蚀能力之间也存在相关性(P<0.01)。但p16表达与中耳胆脂瘤侵蚀能力之间无相关性(P>0.05)。中耳胆脂瘤所有上皮层中EGFR、Ki67、p16的表达均呈强阳性染色,尤其是在基底层和棘层。对照组仅基底层有轻微染色。
与胆脂瘤患者外耳道皮肤及健康人群相比,中耳胆脂瘤中EGFR、Ki67、p16的表达显著升高。EGFR或Ki67的表达与中耳胆脂瘤侵蚀能力之间存在相关性。这意味着EGFR、Ki67和p16在中耳胆脂瘤的过度增殖中起关键作用。